Clinical Research Directory
Browse clinical research sites, groups, and studies.
Retinol Binding Protein 4 Protein in Alopecia Areata Treated With Barcitinib
Sponsor: South Valley University
Summary
Assess serum and tissue retinol binding protein 4 in patients with severe alopecia areata in correlation with healthy individuals . Estimate genetic profile of retinol binding protein4 in severe alopecia areata patients Assess possible role of retinol binding protein 4 genetic mutation in response to barcitinib treatment in patients with severe alopecia areata .
Official title: Retinol Binding Protein 4 Expression and Its Genetic Variants in Severe Alopecia Areata Treated With Barcitinib.
Key Details
Gender
All
Age Range
12 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2023-09-01
Completion Date
2024-10-30
Last Updated
2024-08-09
Healthy Volunteers
No
Conditions
Interventions
Baricitinib Oral Tablet
Baricitinib 2/4mg giving to patients with sever alopecia areata after assessment Retinol Binding Protein 4 and its genetic variations.
Locations (1)
South Valley University
Qina, الكيلو 6 Qena - Safaga Rd, Qena, Qena Governorate, Egypt